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A. Historical Background on Nicotine- and Lobeline- induced Emesis. 
Nicotine and lobeline long have been known to be emetic agents. Smoking 
of tobacco, particularly by the uninitiated, is ass09iated with nausea, 
gastrointestinal distress and frequently vomiting. That lobeline has actions 
similar to nicotine was demonstrated by the Rev. Manasse Gutler who in 1775 
introduced the crude drug into medicine as an emetic (Whitehead and Elliott, 
1927). Samuel Thomson so extensively employed the crude extracts of Lobelia 
inflata in his system of medicine that he commonly was called an "Emetic 
Doctor" (Ball, 1925). Nicotine was first isolated by Posselt and Reimann 
(see Jackson, 1941) and lobeline by Weiland and Mayer (see Norris and Weiss, 
1927). According to Weiland and Mayer, alpha-lobeline does not possess any 
emetic action or stimulate autonomic nerve endings, but is a specific respiratory 
stimulant. The efficacy of this agent as an emetic, however, has been adequately 
demonstrated by Camp (1927) and by Norris and Weiss (1927). 
Ni~otine was shown to produce vomiting in eviscerated animals (Eggleston 
and Hatcher, 1915) and after topical application to the floor of the fourth 
ventricle (Hatcher and Weiss, 1923). Both groups concluded that nicotine acts 
by direct stimulation of the medullary vomiting center. To the writer's know-
ledge, no further experimentation has been conducted to establish more definitely 
the locus of the emetic action of this drug. 
In the past few years, Borison and Wang have presented evidence (which will 
be reviewed in the next sections of this thesis) to establish the fact that no 
emetic agent acts by direct stimulation of the vomiting center. All emetic 
stimuli have been demonstrated to act at other loci and to activate the emetic 
center through afferent nervous pathways. Therefore, it was felt profitable to 
reinvestigate the emetic action of nicotine in the light of the more modern con-
cepts of the emetic mechanism and to establish more definitively its locus of emetic 
action. 
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Eggleston (1916) found that intrav~nous atropine, in doses of 0.0035 -
0.05 mg./kg., reduoed the inoidence of emesis in response to subsequently ad-
ministered niootine. He believed that nicotine acted directly on the vomiting 
center and that atropine desensitized that portion of the vomiting center then 
believed to be responsive to nicotine. However, Hatcher and Weiss (1928) were 
unable to prevent the vomiting response to parenterally administered nicotine 
by prior application of atropine to the dorsal medullary surface and they concluded 
that the heart is the site of the emetic action of nicotine, for atropine was 
then believed to block visceral afferent impulses from that organ. Cheymol and 
Quinquaud, on the other hand, did find that topical application of atropine 
(1950) to the medulla oblongata, as well as of ergotamine (1948), blocked nicotine-
induced emesis. In addition, Hatcher and French (1932) also found that ergotamine, 
administered intramuscularly, reduced the incidence of nicotine-induced vomiting. 
Thus the evidence available indicates that nicotine acts at some as yet undefined 
locus elsewhere than in the gastrointestinal tract to produce vomiting. 
Anti-emetic properties also have been claimed for nicotine. Eddy and 
Hatcher (1928) found that nicotine, given repeatedly at half-hour intervals, 
made cats refractory to the emetic effects of squill. Other animals which were 
treated similarly with nicotine, vomited in response to apomorphine; thus, the 
procedure was not believed to impair the functional integrity of the vomiting 
center. A similar protective effect of nicotine was observed by Hatcher and 
Weiss (1928) against oubain, strophanthin, and cymarin. Regardless of the degree 
of protection afforded by nicotine, the fact that all of the animals tested with 
digitalis died soon after the drug administration complicates interpretation of 
these results. 
Edmunds in 1904 demonstrated that small doses of an amorphous extract of 
Lobelia caused repeated vomiting in cats but that larger doses caused only 
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Panting and convulsions without emesis. This author states that the locus of the 
emetic action is on the vomiting center because larger doses are required orally 
than parenterally to produce similar emetic effects. Norris and Weiss (1927) also 
were able to produce vomiting in cats with alpha-lobeline, thus disputing the result 
of Weiland and Mayer (see above). Norris and Weiss also found that atropine blocked 
the emetic effects of alpha-lobeline; these results paralleled those of Eggleston 
(1916) for nicotine. Alpha-lobeline-induced vomiting also has been produced in 
dogs, even after sedation with chloral hydrate (Camp, 1927). 
Hatcher and Weiss (1923) found that removal of either the corpora quadri-
gemina or the cerebellum failed to prevent the vomiting to lobeline. Decere-
bration of the cat has been shown not to prevent the emetic response to lobeline 
sulfate (Borison and Wang, 1949). Borison and Fairbanks (1952) have shown that 
bilateral nodose ganglionectomy failed to make cats refractory to this agent. 
Clementi (1936) foun~ that lobelanine and lobelanidine, secondary alkaloids 
of Lobelia inflata, both caused vomiting when administered either subcutaneously 
or topically to the dorsal medullary surface. In addition,lobelanine caused 
respiratory stimulation and convulsions, whereas lobelanidine was devoid of such 
effects but had stronger curariform and emetic properties. Lendle and Richter 
(1950) and Richter (1939) disputed the results of Clementi, stating that lobelanine, 
lobelanidine and even lobeline were inactivated in the gastrointestinal tract or 
in the liver and that the emetic potenoy of Lobelia tincture was dependent upon 
the isolobinine content, which they found to induce vomiting reflexly by stimulation 
of the gastric mucous membrane. 
Nicotine and lobeline are practically devoid of therapeutic importance but 
are of considerable pharmacological and toxicological interest. Their actions 
are similar in that both first stimUlate and, with higher doses, depress auto-
nomic ganglia, adrenal medulla, and central nervous system. They have a curariform 
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action on skeletal muscle, and directly stimulate the vascular and intestinal 
musculature. Furthermore the peripheral respiratory chemoreceptors and the 
medullary respiratory and vasomotor eenters are stimulated and the hypothalamic-
hypophyseal structures are aetivated with consequent release of ADH. Whereas the 
respiration can be blocked at the medullary level by both of these drugs, the 
doses required are higher than those which bring forth the curariform properties 
of the d~ugs and death is due to skeletal museular paralysis (Goodman and Gilman, 
1955) • 
The ubiquitous pharmacological actions of these alkaloids in the body 
necessitate the formulation of a comprehensive plan of investigation in order 
to determine the locus of a specific action. An attempt at such an investigation 
is presented in this thesis. For the sake of orientation in this complex field 
of investigation, it seems desirable to review briefly the current concepts of the 
central emetic mechanisms and the present knowledge of the receptor sites and 
afferent pathways involved in emesis. 
B. Current. Concepts of the Oentral Emetic Mechanisms. 
Vomiting is a complex, eoordinated process which involves both somatic and 
visceral muscular activity. Prodromata of vomiting include salivation, licking 
and swallowing, changes in respiration, assumption of characteristic posture and 
finally retching. The emetic act usually is preceded by a series of coordinated 
pumping movements of the thoracic and abdominal respiratory musculature, follow-
ing closure of the glottis, forward extension of the neck, opening of the mouth 
and protrusion of the tongue. The actual expulsion of the vomitus occurs at the 
peak of a sustained inspiration. 
A large number of functional units are thus brought into play in a systematic 
manner in order to accomplish the vomiting act. It can readily be seen why 
Giannuzzi, in 1865, postulated the existence of a "center" to control this 
panorama of events (see Borison and Wang, 1953). Thumas claimed to have 
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localized this "center n when, in 1891, he ablated structures in the midline 
region of the calamus scriptorius and found his animals refractory to the emetic 
effects of apomorphine, tartar emetic and central faradic vagal stimulation. 
Hatcher and Weiss (1923) disputed the results of Thumas because they found that, 
while the le~ion which Thumas described resulted in refractoriness to parenteral 
apomorphine, it did not prevent the vomiting to oral mercuric chloride. These 
workers believed the vomiting center to be located superficially in the region of 
the ala cinerea, for lesions here resulted in refractoriness to both emetic 
agents. However, this conclusion was based only on acute experiments and sub-
sequent investigations in this field have demonstrated that results from acute and 
chronic experimentation are frequently at variance. The more recent historical 
development of investigations on the mechanism of vomiting have been reviewed 
by Borison and Wang (1953), and the older literature by Hatcher and Weiss (1924). 
The first strong evidence for the location of the vomiting center was 
presented by Borison and Wang (1949) who reported that electrical stimulation, 
in the cat, of an area in the dorso-lateral reticular formation and impinging 
upon the tractus solitarius produced emetic responses. These positive results 
placed the center deep to the surface of the medulla; stimulation of the more. 
superficial structures, which had been implicated by earlier workers, failed to 
cause vomiting. This finding has been confirmed recently by Kuru and Sugihara 
(1955) although these workers stress the involvement of the fasciculus solitarius 
to a greater extent than do Borison and Wang. 
To investigate further the role of the superficial medullary structures, 
Wang and Borison (1950) prepared chronic animals in which superficial as well 
as deep structures were destroyed by electrocautery. Moreover, they were able, 
with the use of radon implants, to destroy selectively the dorso-lateral reticular 
tissues without damaging surface structures (Wang and Borison, 1951). Both the 
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surface and the deep structures were found to be important in emesis, the former 
to be the receptor site for the emetic action of apomorphine (emetic chemoreceptor 
trigger (CT)-zone), whereas the latter was recognized to be the vomiting center 
]!!!!_ The superficial area in the region of the ala cinerea was inactive, how-
ever, in the absence of the emetic center. 
Additional support for the localization of the emetic center in the medulla 
is seen in the experiments of Thumas (1891) who produced vomiting with apomorphine 
in a dog after brain stem section at the level of the acoustic striae_ Hatcher 
and Weiss (1923) indueed emesis with lobeline after cerebellectomy, as previously 
mentioned. Borison and Fairbanks (1952) reported that cats vomited to Veriloid 
following low cervical cord section. It is evident therefore that, provided the 
neural motor pathways essential for the accomplishment of the vomiting act are 
intact, the medulla oblongata alone is capable of coordinating the functional 
systems necessary to produce vomiting. It is this coordination of functions which 
is the essence of the modern concept of the emetic center. The center, as des-
cribed by Borison and Wang (1949) and Kuru and Sugihara (1955), is located dorsal 
to the inspiratory component of the respiratory integrator mechanism, and ventral 
to the respiratory pacemaker area (Brodie and Borison, 1957) and to the area con-
trolling spasmodic respiratory acts (Borison, 1948). In addition, it lies 
immediately ventral to the salivatory nuclei (Wang, 1943), and in the midst of the 
reticular formation demonstrated by Magoun (1950) to modify somatic motor activity. 
This aggregation of functional units acts in a cohesive fashion to organize the 
entire body for the accomplishment of emesis. The vomiting center is therefore 
not an isolated center, but rather an integrator mechanism at which the afore-
mentioned centers produce vomiting by combined forces. 
The CT-zone has been seen to be a receptor site, functioning through the 
emetic center. Thus, certain centrally-acting emetic agents have been shown 
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to act external to the vomiting center~ Indeed, in subsequent experimentation 
based on this new working hypothesis, no agent has been found to produce emesis 
by a direct action on the medullary reticular center. This conclusion is supported 
by the fact that it can always be demonstrated that animals insensitive to one 
class of emetic agents, as a result of interruption of certain afferent pathways, 
can be made to vomit following the administration of a member from another class 
of drugs. In this way it can be demonstrated irrefutably that selective refractor-
iness to an emetic agent is due to interruption of a particular pathway or pathways 
and not due to non-specific central neuronal depression or motor incapacitation of 
the emetic reflex mechanism. 
C. Receptor Sites and Afferent Pathways in Emesis. 
A list of the postulated receptor sites for the emetic action of various 
agents is presented in table 1. It will be seen that electrical stimulation of 
three areas rostral to the rhombencephalon has been shown to cause vomiting 
(Penfield and Rasmussen, 1950; Hess, 1954; Penfield and Welch, 1951). The emesis 
from these rostral structures occurred only after prolonged stimulation or after 
st'imulation had ceased. Therefore it seems probable that these are not primary 
emetic canters, if they are centers at all, and that they probably can be con-
sidered as receptor sites sending afferents to the bulbar center. However, these 
tissues have never been stimulated following excision of the medullary center and 
can not be excluded as independent secondary centers. Stimulation of the para-
central sulcus in the human (Penfield and Welch, 1951) has been found to cause a 
"desire to vomit" and may therefore be more closely affiliated with the psyche 
than with efferent activity. 
Many agents are listed as acting by stimulation of the CT-zone of the medulla 
oblongata. The evidence in favor of apomorphine, morphine and Hydergine acting 
at this site seems well substantiated. However, an action of X-radiation here is 
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~blel. Proposed Sites of Action of :&netic Agents in the Body. 
~. 
)breviations used for routes of administration: I.V. = intravenous; P.o. = per os; 
3 V. = per third ventricle; ~.V. ~ per lateral ventricle; I.T. = intrathecally; 
I.P. = intraperitoneally. 
I. Cerebral 
Agent Route Species Locus of Action Pathway Reference 
Lectrical Human Island of Reil Direct to medullary Penfield & Rasmu 
t, imulat ion center or through 1950 
a hypothalamic 
relay 
lectrical Human Paracentral sulcus* as above Penfield & Welch 
timulation 1951 
itrogen I.V. Cat Cerebral cortex (1) as above Brand et &., IS 
ustard 
ilocarpine I.V. Cat Frontal lobe as above Borison !i !!., 
ilocarpine L.V. Human Hypothalamus as above Cushing, 1931 
pituitrin 
cetylcholine L.V. Human - Henderson & Wils 
, eserine 1936 
eostigmine I.T. Human 
-
Kremer, 1942 
;serine L.V. Cat 
-
Feldberg & She~ 
1954 
,taphylococcus I.P. Cat Hypothalamus as above Borison et al. 
mterotoxin (BaYliss-;-1940~ ~ 
aectrical Cat Hypothalamus as above Hess, 1954 
Itimulation lateralis 
r "Desire to vomitu produced 
- Emphasized role of the vagus 
- Not specified by authors 
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able 1. (cont.) 
II Lower Brain Stem • 
I 
Agent Route Species Locus of Action Pathway Reference 
1ectrical Cat Lateral reticular Borison &;,Wang, 
timulation formation 1949 
.. 
pomorph ine I.V. Dog CT-zone Transmedullary Wang &: Borison, 
1950; 1951; 1952 
;orphine I.V. Dog CT-~one Transmedullary Wang &: Glaviano, J 
ydergine I.V. Dog CT-zone Transmedullary Wang &: Glaviano, J 
ardiac- I.V. Dog CT-zone Transmedullary Borison &: Wang, l~ 
lycosides Wang &: Borison, l~ 
early phase) 
·ardiac- I.V. Cat CT-zone Transmedullary Borison & Brizzee~ 
;lycosides 1951 
early phase) 
:ardiac- .3 V. Dog CT-zone # Transmedullary Weinberg &: Haley, 
:lyoosides Haley, 1956 
!opper I.V. Dog CT-zone Transmedu11ary Wang &: Borison, l~ 
lulfate 1952 
:-radiation Dog CT-zone Transmedullary Chinn & Wang, 1951 
~-radiation Monkey CT-zone (?) Interposed Brizzee et 801., l~ 
transmedullary 
1otion Dog CT-zone (?) Vestibulo- Wang & Chinn, 1951 
cerebellar 
~otion Dog Labyrinth Vestibu1o- Tyler & Bard, 194~ 
cerebellar Wang & Tyson, 195L 
Wang & Chinn, 195t 
Chinn & Smith, 19~ 
# Proposed site, not supported by direct evidence. 
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Table 1. (cont.) 
I:' 
., ~":' • 
er:pJer III P i h al 
~.' ~"t 
Agent Route Species Locus of Action Pat~way Reference 
Electrical Cat Vagus Miller, 1910 
stimulation 
Electrical Cat, Vagus Derbyshire & Fer~ 
stimulation dog 19.38 
Electrical Cat Nodose ganglion See Borison & W~ 
stimulation 195.3 
Mustard P.O. Cat Stomach Vagus Miller, 1910 
Distention DQg Pylorus Vagus Goldberg, 19.31 
of gut Herrin & Meek, 1 ~ 
Distention Dog Gall bladder, Vagus, left Schrager & Ivy, : 
of gut biliary passages splanchnic 
Distention Cat Ligation of Franklin & McLacl 
of gut Mesenteric vein 1937 
E. coli Visceral Vagus, Walton !1 !!,., l~ 
(peritonitis) per it onium sympathetic 
Cardiac P.O. Dog Parenteral Wang & Borison, J 
glycosides 
(late phase) 
Cardiac P.O. Cat Parenteral Borison, 1952 
glycosides 
(late phase) 
Cardiac I.V. Pigeon Liver, abdominal Vagus Hanzlik & Wood, , J 
glycosides viscera 
Copper P.O. Dog Gut mucosa Vagus, Wang & Borison, J 
sulfate splanchnic 1952 
X-radiation Cat Abdomen Vagus, lower Borison, 1957 
thoracic sensory 
roots 
X-radiation Monkey Abdomen Vagus Brizzee, 1956 
Veratrum I.V. Cat Nodose ganglion Vagus Borison & Fairb~ 
1952 
Tanaka & Kanno, J 
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disputable. Chinn and Wang (1954) found that lesions in the CT-zone made dogs 
uniformly refractory to the emetic effects of X-radiation despite the fact that 
irradiation only of the head never was effective in evoking emesis. Brizzee (1955) 
reported that ablation of the area postrema of the monkey blocks the vomiting to 
X-radiation but later found that supradiaphragmatic vagot~ alone made this 
species insensitive (Brizzee, 1956). Borison (1957) states that cauterization of 
the CT-zone in cats results in uncertain and unpredictable effects on radiation-
induced emesis. This author believes that, for the cat at least, the locus of 
action is in the abdomen, for supradiaphragmatic vagotomy combined with bilateral 
dorsal rhizotomy of the lower thoracic segments of the cord desensitizes the animal, 
as does shielding the abdomen. Therefore, whereas ablation of the CT-zone can 
cause emetic refractoriness to X-radiation, this area can not be the direct site 
of action in the cat and the monkey. Neither can the CT-zone be the site of 
action of a humoral agent released as a result of irradiation since, in the cat, 
other agents are effective· in stimUlation of the CT-zone at the same time that 
radiation is ineffective as an emetic, following interruption of afferent pathways 
from the abdomen. 
Cardiac glycosides and copper sulfate, when administered intravenously, 
are believed to have their primary emetic action at the CT-zone (Wan~ and Borison, 
1951, 1952; Borison and Wang, 1951; Borison and Brizzee, 1951; Borison, 1952). 
However, in the cat, Borison (1957) has found no consistent relationship between 
the emetic responses to apomorphine and to the cardiac glycosides following lesions 
made in the area postrema. Cats can be refractory to either one or both of these 
agents and no consistent neurological difference could be detected histologically 
in lesions of different effectiveness. The evidence indicates that either there 
are two morphologically and/or physiologically distinct receptor sites in the CT-zon. 
or that one of these agents is acting peripherally. Apomorphine produces emesis 
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following topical application to the medulla (Hatcher and Weiss, 1923). Its 
action is prevented by parenteral administration of chlorpromazine, also believed 
to act at the CT-zone (Brand at al., 1954; Glaviano and Wang, 1955; Cook and Toner, 
1954). In addition, cisternal injections of chlorpromazine make animals insensitive 
to subsequent injections of apomorphine (Glaviano and Wang, 1955). The cardiac 
glycosides or copper sulfate still cause emesis when administered intravenously 
following injections of chlorpromazine and the cardiac glycosides are not 
effective by topical application to the dorsal medullary surface. 
The controversial nature of the evidence which has been accumulated in the 
study of emesis, particularly as regards the locus of emetic action of X-radiation 
and the cardiac glycosides, makes it imperative that a reinvestigation of the 
problems be carried out. Such a reappraisal is especially warranted in the light 
of a recent series of neuro-anatomical investigations. Liu (1956) has demonstrated 
that, following section of the dorsal roots of the spinal cord of the cat, the 
intraspinal fibers which degenerate traversed the posterior funiculus and terminated 
on the dorsal surface of the medulla at the level of the inferior olivary nucleus. 
Most interesting, perhaps, is the fact that section of the more caudal thoracic 
roots, namely, those innervating the abdominal viscera, resulted in degeneration 
of fibers which terminated in the periventricular areas of the medulla oblongata. 
Kuru (1956) has shown more definitely for the cat, dog, monkey, goat, guinea pig, 
and human that nerve fibers originating at thoracic, lumbar, and sacral levels 
course through the antero~ateral funiculus of the spinal cord and terminate in the 
region of the nucleus paraalaris, nucleus juxtasolitarius, and ventral to the de-
scending root of the trigeminal nerve. In the same article, Kuru reports that 
section of the lateral fascicle in a tabetic patient at the bulbo-spinal junction 
alleviated gastric crises associated with vomiting. Rostral degeneration took the 
course of the aforementioned spinobulbar tracts. Kahn (1933) and Kahn and Barney 
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(1937) similarly relieved gastric crises in eight tabetic patients by anterolateral 
chordotomy at the level of the eighth cervical segment. Kuru and Sugihara (1955) 
have attempted to implicate these pathways in emesis. These authors state, " ••• the 
chemoreceptor trigger zone mentioned by both authors (Borison and Wang, 1951; 
Hatcher and Weiss, 1923), situated between the ala cinerea and the vestibular com-
plex and medially contiguous with the area postrema which overlies the ala cinerea, 
corresponds fairly to the site of termination of the thoraco-bulbar tract". 
Certainly the proximity of the paraala nucleus of Kuru to the area postrema 
suggests the possibility that fibers in this area may be interrupted inadvertently 
in the process of ablating the CT-zone. The limitations imposed by the techniques 
for making discrete lesions favor such a postulate. Further support to this 
suggestion is given by the reports of Borison (1957) and Bri~zee (1956) who found 
that, whereas ablation of the CT-zone reduced the sensitivity of the cat and monkey, 
respectively, to radiation-induced emesis, peripheral lesions were also effective. 
Therefore, it can be stated that the medullary lesions interrupted afferent path-
ways and did not destroy receptor sites. Nevertheless, the evidence for a direct 
action on the CT-zone of certain agents, namely, apomorphine, morphine, and the 
ergot alkaloids, appears to be more certain than for the cardiac glycosides. This 
region may be likened to a funnel which channels stimuli to the emetic center, but 
exactly which agents have their site of action within the "funnel" seems less 
certain than previously thought. Ablation procedures will have to be refined to 
produce more circumscribed lesions so as to rule out, as far as possible, the 
destruction of neighboring pathways. In addition, histochemical techniques may 
have to be employed to exclude, if possible, the existence of multiple receptors. 
Emetic receptors which are located in the neck and trunk and which respond 
to pharmacological, mechanical, or electrical stimuli are listed in table 1. 
Possible stimulation of any of these loci as well as all the suprasegmental sites 
mentioned must be considered when analyzing the mechani~ of action of a new emetic 
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agent 0 In addition, one must seek new sense organs capable of initiating afferent 
emetic impulses and consider as well the possibility of multiple sites of action. 
D. Anti-Emetic Drugs. 
The ideal anti-emetic drug is one which, in non-toxic doses, selectively pre-
vents vomiting from any cause. The logical site of action for such an agent would 
be the medullary vomiting center, for this is the single locus of integration for 
all emetic stimuli. However, the vomiting center located in the medullary reticular 
formation, as previously mentioned, is so intimately concerned with the vital 
function of respiration that depression of this center can only lead to concomitant 
respiratory depression. One must therefore look to the specialized receptor sites 
for the individual emetic stimuli to find the loci at which such an antagonism could 
take place. The selectivity of emetic receptors for drugs of widely different 
pharmacological classes also militates against the possibility of discovering a 
universally-effective anti-emetic drug which could act simultaneously at all re-
ceptor sites. We are, therefore, forced to direct our efforts towards finding 
agents which act either at specific emetic receptor sites, and thereby antagonize 
only the emetic action of drugs, or which pharmacologically oppose all of the action! 
of an emetic agent. Earlier research has identified drugs of both groups: chlor-
promazine - an agent which acts selectively at the CT-zone and blocks the emetic 
action of apomorphine, morphine, and Hydergine (Brand et !l., 1954), and atropine -
an antagonist which blocks all of the muscarinic actions of pilocarpine including 
the vomiting response to this drug (Kwit and Hatcher, 1933). Drugs of the former 
class are more desirable for they permit expression of other, possibly beneficial, 
actions of the emetic SUbstance. 
Four drugs were chosen as candidate anti-emetic agents in the present study: 
chlorpromazine, atropine, tetraethylammonium (TEA), and hexamethonium (C6). The 
efficacy of chlorpromazine against clinical drug-induced emesis and vomiting 
secondary to a variety of clinical disorders has been reviewed recently by Connor 
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and Moyer (1956) and need not be considered here. Reports of investigations con-
cerning the ability of chlorpromazine to inhibit vomiting in experimental animals 
have been more limited; but they have indicated that the site of anti-emetic action 
of this drug is the CT-zone. Brand et al., (1954) showed that chlorpromazine 
(105 mg./kg. S.C.), in the dog, raised the threshold for apomorphine-induced emesis 
from two and one-half to four times and prevented vomiting to uniformly effective 
emetic doses of morphine and Hydergine, whereas it was ineffective in protecting 
against intravenous veratrum, lanatoside-C, and copper sulfate. In cats, on the 
other hand, chlorpromazine failed to inhibit vomiting to drugs which act at the CT-
zone, although it reduced the incidence of vomiting to intravenous pilocarpine. 
Glaviano and Wang (1955) demonstrated that chlorpromazine (2.0 mg./kg. S.C.) raised 
the threshold for apomorphine- and Hydergine-induced emesis in dogs but they were 
able to show only moderate protection against morphine with intravenous doses of 
chlorpromazine up to 6 mg./kg. In contrast, this dose of chlorpromazine afforded 
complete protection against the emetic action of oral copper sulfate, indicating to 
the authors that there was depression of the medullary reticular vomiting center. 
While this appears to be the most probable explanation, it fails to explain the 
inability of the drug to prevent vomiting to morphine. Boyd et al., (1954) and 
Cook and Toner (1954) also found that chlorpromazine reduced the incidence of apo-
morphine-induced emesis in dogs. The same type of antagonism has been demonstrated 
in man by Isaacs and MacArthur (1954), who showed that chlorpromazine reduced the 
incidence of vomiting to SUbcutaneously administered apomorphine from 45 percent 
to 4 percent. 
Chinn and Sheldon (1954) found that chlorpromazine afforded significant pro-
tection against radiation-induced vomiting in the dog, whereas Borison!i !l., (1955 
showed that, in the cat, this agent had only a weak inhibitory action against vomit-
ing due to radiation o Cook and Toner (1954) and Chinn and Smith (1955) have reporte 
that chlorpromazine is effective against swing sickness in dogs but not in humans. 
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Gujral !i al., (1956) and Madjerek and Stern (1956) were unable to inhibit 
vomiting to digitalis in the pigeon with doses of chlorpromazine up to 10 mg./kg. 
administered intramuscularly. However, Gujral !i !l., showed that chlorpromazine 
did reduce the incidence of emetine-induced vomiting in this species. 
The use of atropine as an anti-motion sickness agent has been reviewed by 
Tyler and Bard (1949) and more recently by Chinn and Smith (1955). The use of atro-
pine as an antagonist of drug-induced vomiting is reviewed briefly below. Eggleston 
(1916) showed, in dogs, that atropine blocks the vomiting which follows pilocarpine 
and nicotine but not that which follows morphine, apomorphine, emetine, aconitine, 
or oubain. Indeed, as little as 0.0035 mg./kg. atropine base, intramuscularly, was 
reported to block vomiting to 0.35 mg./kg. nicotine base given by the same route. 
Norris and Weiss (1927) similarly reported that atropine reduced the incidence of 
vomiting to lobeline. Unfortunately, Norris and Weiss did not present data to 
support their statement. Koppanyi (1930) found in dogs that introduction of copper 
sulfate and,cephaeline into a duodenal pouch produced emesis, and that a high con-
centration of atropine by the same route blocked the vomiting. Intravenous atropine, 
however, was ineffective. It seems likely that a~ropine, under these conditions, act 
as a local anesthetic. Hatcher and Weiss (192B) showed that atropine reduced the 
frequency but not the incidence of strophanthin-induced vomiting in cats. Kwit and 
Hatcher (1933) demonstrated that atropine prevented both the emesis and the pre-
emetic prodromata following pilocarpine administration in the cat. On the basis 
of this antagonism, the authors postulated that pilocarpine had a peripheral site 
of emetic action, most probably at the heart. Borison et al., (1956) have shown, 
however, that pilocarpine acts on frontal lobe structures to produce emesis. Atropin 
injected either intramuscularly or into the lateral cerebral ventricles, prevents 
vomiting to a subsequent intraventricular injection of either pilocarpine or pituitri: 
(Cushing, 1931). 
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Swiss (1952) used tetraethylammonium (TEA), fS well as scopolamine, atropine, 
I 
I 
ephedrine, Dibenamine, and methanthaline in an ~ttempt to find a pharmacological 
antagonist of veratrum-induced emesis in dogs. None of these agents blocked the 
vomiting to veratrum. Busse and Lendle (1953) screened ~A, pendiamide, and 8CO-
polamine-N-bromobutylate, as well as nicotine, procaine, papaverine and Dibenamine 
for anti-emetic potency against nicotine, apomorphine, pilocarpine and the digitalis 
glycosides. TEA (10-20 mg./kg.), pendiomide (0.2 mg./kg.), and scopolamine-N-
bromobutylate (10-20 mg./kg.) were effective in preventing nicotine-induced vomiting, 
In addition, the scopolamine salt was effeetive in preventing vomiting to pilocar-
pine. None of the other drugs listed was found to have anti-emetic potency against 
apomorphine, nicotine, pilocarpine, or the digitalis glycosides. 
To the author's knowledge, hexamethonium (06) has never been assayed for anti-
emetic potency. However, in view of the fact that Busse and Lendle (12£.~.) 
demonstrated that drugs with ganglionic blocking properties could inhibit nicotine-
induced emesis in dogs, it was thought profitable to test 06 against nicotine and 
lobeline-induced emesis, as well as to extend these stUdies to include cats. 
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METHODS 
A. General Procedures. 
Twenty-one acute and forty-five chronic experiments were performed on cats 
and ten chronic experiments were performed on dogs, for localization of site of 
emetic action of nicotine and lobeli~e. All acute surgery was performed under 
ether anesthesia and the cats were tested at least one hour after discontinuation 
of the anesthetic. Chronic animals routinely were given 300,000 units of procaine 
penicillin in aqueous solution intramuscularly immediately after surgery. Animals 
which did not eat voluntarily in the post-operative state were either force-fed 
orally or maintained with parenteral glucose and saline solutions. Whenever possible 
animals were fed ~ediately before testing with the emetic agents. In cases in 
which the abdominal musculature was paralyzed, owing to spinal transection, a 
binder was put on the abdomen so as to facilitate the mechanical process of vomiting. 
For routine drug tests, animals were selected at random from a stock supply and 
they were fed shortly before injection. Caution was exercised to avoid reuse of 
animals at short intervals. The animals were restrained only during injection of 
the drugs. Cats were returned to their cages and dogs were collared and restricted 
to a small area. All animals were observed constantly for at least 30 minutes 
after injection of either nicotine bitartrate or lobeline sulfate, unless vomiting 
occurred earlier. Nicotine bitartrate and lobeline sulfate in physiological saline 
solution were prepared fresh on the day of the test. These alkaloids were injected 
intramuscularly. Atropine sulfate, TEA bromide, and C6 chloride also were dissolved 
in physiological saline solution on the day of the test. In the drug antagonist 
studies, TEA and c6 were injected 10 minutes and atropine and chlorpromazine 30 
minutes before nicotine bitartrate or lobeline sulfate. TEA, C6, and atropine 
were injected intramuscularly; chlorpromazine was injected subcutaneously. 
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B. Surgical Techniques. 
1. Decerebration. The common carotid arteries were ligated in the mid-
cervical region. The cranium was then opened and'the dura mater incised. A 
flexible spatula was inserted along the rostral surface of the tentorium and the 
brain stem sectioned at the level of the superior colliculi. The forebrain was 
then removed and the cavity packed with cotton soaked in physiological saline 
solution. 
2. Vagotomy. 
one of three levels: 
The vagus nerves were sectioned under aseptic conditions at 
a) supradiaphragmatic, b) subclavian, and c) mid-cervical. 
In the case of the supradiaphragmatic and right subclavian vagotomies, the animals 
were maintained on positive pressure artificial ventilation while the pleural 
cavity was open. The procedures were accomplished by the most direct surgical 
approach. In the case of bilateral mid-cervical vagotomy, it was necessary to 
establish an airway prior to section of the vagus nerves which include the re-
current laryngeal nerve. This was accomplished by one of the following operations: 
a) vocal cord removal, b) establishment of a tracheal fistula, or c) insertion of 
a tracheal cannula. 
3. Spinal Cord Transection and Dorsal Rhizotomy. The desired segment ( s) of 
the spinal cord was located by use of the spinous process of the first thoracic 
vertebra as a point of reference. The soft tissues were separated from the bone 
and a laminectomy was performed. In the ca.,se of spinal cord transection, only 
the dorsal surface of the dura was incised, thus preventing dislocation of the 
cord after transection. A similar surgical approach was carried out for sectioning 
the dorsal roots. After laminectomy, the roots were cut either intradurally or 
extradurally. When the rhizotomy was performed in~radurally, the dura was incised 
longitudinally and the dorsal roots were lifted and sectioned at the point of 
entry into the cord. In order to section the roots extradurally, the laminectomy 
had to be extended laterally and the intervertebral fat pads removed. The dorsal 
roots were lifted and sectioned central to the ganglion. 
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4. Medullary Lesions. The animal was maintained on positive-pressure arti-
ficial ventilation so as to prevent death fram apnea which might result fram 
temporary medullary depression due to the surgical trauma. The head was fixed in 
a head holder and ventrof1exed to permit complete exposure of dorsal structures. 
The skin and soft tissues were incised with a cold cautery scalpel and retracted 
widely. The foramen magnum was then extended dorsally and laterally and the dura 
and arachnoid membranes were cut. The cerebellum was lifted with a spatula and 
the floor of the fourth ventricle exposed. Superficial lesions were made on the 
dorsal medu11ar,r surface with either a heat cautery or, in a few cases, with a 
sharp curved scalpel blade. The dura was approximated at two or three points and 
the incision closed. 
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RESULTS 
A. Emetic Dose of Nicotine Bitartrate and Lobeline Sulf_te. 
• 
Prior to experimental analysis of the emetic mechanism, it was necessary to 
establish consistently effective emetic doses of nicotine bitartrate and lobeline 
sulfate. Cats and dogs w~re injected intramuscularly with doses of these drugs 
ranging from 0.25 to 6.0 mg./kg. The lowest dose of nicotine bitartrate which 
produced emesis in 100 percent of the cats and dogs tested was 1.5 mg./kg. The 
minimal uniformly effective emetic dose of lobeline sulfate for all cats and dogs 
tested was 0.5 mg./kg. It will be seen in table 2, for nicotine bitartrate, and 
in table 3, for lobeline sulfate, that doses up to 6.0 mg./kg. of the drugs also 
consistently produced vomiting. The apparent difference, as seen in these tables, 
is in reality very slight for, as seen ,in figure 1, when calculated as dose of 
alkaloid base the minimal uniformly effective emetic dose is 0.49 mg./kg. of nicotinl 
and 0.39 mg./kg. of lobeline. This close quantitative relationship of the two drugs 
for both species coincided throughout the entire dose-effect relationship. 
The prodromata of vomiting were similar for both species. Both cats and dogs 
exhibited salivation, agitation, increases in respiration leading to panting, and 
frequently defecation and/or micturition. In addition, the pinnae of cats were 
activated and spontaneous ear flicking was seen for the duration of the hyperpnea. 
Cats also vocalized immediately prior to the expulsion of the gastric contents. 
The respiratory change and salivation, as well as agitation, were also seen after 
doses which were ineffective in evoking emesis. 
In a few cases, the dosages used exceeded 6.0 mg./kg. One cat received 
12.0 mg./kg. of lobeline sulfate and another 36.0 mg./kg. of this agent. The 
response to the lower of the two doses differed from that already described only 
in degree, whereas the higher dose evoked, in addition, a series of clonic con-
vulsions approximately 12 minutes after the injection. This cat vomited after a 
prolonged latency of 85 minutes. 
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Table 2 
EMETIC DOSE-RESPONSE RELATIONSHIP OF NICOTINE BITARTRATE (I.M.) 
DOSE CATS DOGS 
mg.-,kg. No. tested No. vomited Latency , No. tested No. vomited Latency 
(range} (range) 
min. min. 
0.25 8 1 6 
0.5 10 6 5.5(3-9) 6 1 10 
1.0 12 8 '7.5(4-15) 8 7 10.6(5-15) 
1.5 11 11 8.1(4-15) 14 14 9.2(7-14) 
2.0 4 4 4.9(4-7) 
3.0 4 4 5.8(4-8) 4 4 7.7(5-12) 
6.0 3 3 2.8(2.5-3) 4 4 7.3(5-9) 
12.0 10 6 12.6(4-27) 
Table 3 
EMETIC DOSE-RESPONSE RELATIONSHIP OF LOBELINE SULFATE (I .M.) 
DOSE CATS DOGS 
mg./kg. No. tested No. vomited Latency No. tested No. vomited La.tency 
(range) (range) 
min. min. 
0.25 3 2 5, 6 2 1 5 
0.5 6 6 5.5(2.5-9) 5 5 6.6 (5-9) 
1.0 6 6 3.9(3-5.5) 6 6 5.2 (3-9) 
2.0 2 2 2.5, 4 
3.0 5 5 3.6(3-5) 
6.0 3 3 3 (2-4) 
12.0 1 1 1 
36.0 1 1 85 
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Ten dogs were injected intramuscularly with 12.0 mg./kg. nicotine bitartrate. 
Within the first three minutes after the injection all of the dogs became ataxic~ 
Concomitantly, salivation became so excessive that the dogs appear$d to be frothing 
at the mouth. Six of the ten dogs vomited between four and twenty-seven minutes 
after the injection; the r~ining dogs did not vomit. Vomiting was so severe 
that the intestinal as well as the gastric contents were expelled. All ten animals 
exhibited relaxation of the nictitating membrane, muscular fasciculations of the 
trunk and extremities, and collapse. Three of the four dogs which failed to vomit 
in response to 12.0 mg./kg. nicotine bitartrate, had a convulsion within the first 
five minutes after injection. 
B.> Sl.ireaioal Results. 
1. Chronic Medullary Lesions. Owing to the importance of the CT-zone as a 
central receptor site for the emetic action of drugs, it seemed desirable to in-
vestigate the possible role of this site in nicotine-and lobeline-induced vomiting. 
Seven dogs with chronic lesions of the CT-zone were tested nine times with the 
standard emetic dose of nicotine bitartrate (1.5 mg./kg. I.M.) and vomiting was not 
evoked in any of the tests. Three of the seven dogs were also refractory to 
100pg./kg. I.V. of apomQrphine--more than five times the average threshold emetic 
dose, thus indicating that the CT-zone had been effectively removed; the remaining 
dogs were refractory to at least 50pg./kg. I.V. apomorphine. 
Two other dogs with chronic ablation of the CT-zone were studied more intensive~ 
The first dog was insensitiv~ to the emetic effects of 3.0 and 6.0 mg./kg. I.M. 
nicotine bitartrate and to 1.5 but not 3.0 mg./kg. I.M. lobeline sulfate. Surprising 
this animal vomited following 50pg./kg. I.V. apomorphine HCl as well as 0.16 mg./kg. 
I.V. desacetyl lanatoside-C,* indicating that the CT-zone had been incompletely ablat~ 
i~ Desacetyl lanatoside-C, according to the manufacturer, has the same toxicity as 
lanatoside-C. Therefore, the desacetyl analogue was administered in doses found 
to be effective for lanatoside-C. 
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The second dog was refractory to 3.0 and 6.0 mg./kg. I.M. nicotine bitartrate and 
3.0 mg./kg. I.M. lobeline sulfate, as well as to 100pg./kg. I.V. apomorphine Hel 
and 0.16 mg./kg. I.V. desacetyl lanatoside-C. The dog vomited, however, folloWing 
200 Jlg.!kg. I.V. apomorphine HC1, indicating perhaps that a few receptor cells in 
the CT-zone still remained functional. 
Of the nine dogs described above, only four gave evidence of having had the 
CT-zone effectively removed by the criterion of refractoriness to at least 100 
pg./kg. of apomorphine HC1. However, all nine ot the dogs showed refractoriness 
of some degree to the emetic actions of nicotine and/or lobeline. 
Results of CT"",zone ablation in cats are presented in table 4 where it can be 
seen that five chronic cats, which became refractory to the emetic action of apo-
morphine and/or desacetyl lanatoside-C as a result of trigger zone ablation, ex-
hibited only inconsistent emetic refractoriness to the same dose of nicotine and 
lobeline as used in the dogs. Indeed, cats 32 (see figure 2) and 36, which were 
insensitive to the emetic actions of standard test doses of both apOlllorphine and 
-
desacetyl lanatoside-C, vomited frequently following injections of nicotine and 
lobeline. 
In view of the relative inability of CT-zone ablation to prevent nicotine-and 
lobeline-induced emesis in cats, it was considered possible that afferent emetic 
pathways adjacent to the CT-zone might be involved in the vOllliting. Therefore, a 
cat was prepared in which the superficial medullary structures, from the lateral 
border of the fourth ventricle to the lateral margin of the clava, and extending 
from the obex to the restiform body, were destroyed by thermal cauterization. 
This cat (cat 42 - figure 2) was refractory to the emetic actions of apomorphine 
HCl (25 mg./kg. S.C.), nicotine bitartrate (3.0 and 6.0 mg./kg. I.M.) and lobeline 
sulfate (2.0 and 6.0 mg./kg. I.M.). The functional integrity of the medullary 
reticular vomiting center was affirmed by the emetic effectiveness of oral copper 













EFFECT OF EMETIC DRUGS ON CATS WITH CHRONIC CT-ZONELESIONS 
,Apomorphine HCl Desacetyl Nicotine Lobeline 
, 25 mg./'kg. S.C. Lanatoside-C Bita.rtrate" Sulfate 
0.16 mg./kg. l.V. 3.0 mg./kg. I.M. 2.0 mg./kg. I.M. 
Cat # 32 -1--1 1-
Cat # 35 I ... - I-II I .;. 
Cat # 36 I - I - I (*) 
Cat # 43 I ';'1';' 1-
Cat # 44 I I 
<") I - - I I I 
.;. = Cat vomited. 
- - No vomiting response evoked. 
<~~) = Cat responded positively three t:imes to 6.0mg./kg. nicotine bitartrate. 
(rr) - Cat vomited to 3.0 mg./kg. nicotine bitartrate after right s~bc~avian and 
left mid-cervical vagot~. 
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but only after an abnormally long latency of more than 6 hours. 
A series of four cats was then prepared with superficial medullary lesions 
which were parallel and lateral to the emetic CT-zone, but did not include the 
CT-zone proper. The lesions also cut across the mid-line at the level of the obex, 
thus forming a continuous incision from the restiform body on one side, to the obex, 
across the mid-line, and then to the opposite restiform body. All four cats vomited 
in response to apomorphine, desacetyl lanatoside-C, nicotine bitartrate and lobeline 
sulfate. This suggested the possibility that medially terminating vagal afferents 
contributed to the emetic response. Thus, two of these four cats were vagotomized 
by the transthoracic approach immediately abo~e the diaphragm. Both cats vomited 
in response to nicotine and one also vomited after a test with lobeline. A vocal 
cord was then removed in one of these supradiaphragmatically vagotomized cats and a 
chronic tracheal fistula established in the other (cat 40 - figure 2). Following 
these procedures, both animals were vagotomized in the mid-cervical region. Vomit-
ing was again evoked with nicotine bitartrate in both these cats. Thus, with the 
vagi excluded as ffnon-essential rt to the response, the possibility remained that 
certain central afferent pathways, which could contribute to the vomiting, may 
have been spared by the superficial medullary lesions already described. Hence, 
a series of extramedullary lesions was performed so as to interrupt definitely all 
accessible ascending and descending afferents (see table 5). 
2. Acute Extramedullary Lesions. Positive responses to nicotine were obtained 
in the following acute experiments: a) decerebration and bilateral mid-cervical 
vagotomy, b) dece~ebration and spinal cord transection at the level of the first 
thoracic vertebra, c) decerebration and bilateral section of cranial nerves V, 
IX, X, XI, and XII. The last one of these preparations retched several times 
following the nicotine bitartrate but it did not vomit owing to severe impairment of 
oropharyngeal function. Another cat was prepared in which the first three lesions 
were combined, namely, decerebration, bilateral mid-cervical vagotomy, and spinal 
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Table 5 
EFFECT OF ACUTE AND CHRONIC EXTRAMEDULLARY LESIONS 
ON EMETIC RESPONSE TO NICetrINE BITARTRATE (3.0 mg./kg. I.M.) 




& Mid-Cervical Vagotomy 
& Spinal Transection (T-2) 
& Section of Nerves V, IX, 
X, XI & XII 
& Spinal Transection {T-l) 
plus Mid-Cervical Vagotomy 
Mid-Cervical Vagotomy 
CHRONIC 
& Spinal Transection (T-5) 
& Spinal Transection (T-l) 
Spinal Transection (T-5) 
Spinal Transection (T-2) 
Supradiaphragmatic Vagotom,y 
& Spinal Transection (T-4) (#) 











& Dorsal Rhizotomy (T-l to T-10) (#) 1 
Dorsal Rhizotomy (C-8 to T-7) } 
& Spinal Transection (T-7) (#) . 
& Right Subclavian & Left 
Mid-Cervical Vagotomy (#) 
1 
1 (it) 
& Mid-Cervical Vagotomy 1 (*) 
(*) • Tested with 6.0 mg./kg. nicotine bitartrate. (iH~) = Retched only, (See RESULTS.) 































cord transection at T-l. This animal failed to vomit to nicotine bitartrate but 
it did vomit to Veriloid. A bilateral mid-cervical vagotomy in combination with 
." 
spinal cord transection at T-l was then performed in three other cats under ether 
anesthesia and the animals were tested one hour after discontinuation of the 
anesthetic. All of these animals were refractory to the emetic effeet of nicotine 
bitartrate at the dose level of 3.0 mg./kg. I.M. One of these animals vomited 
subsequently in response to intravenous pilocarpine. 
In order to determine the extent of spinal cord involvement in nicotine-induced 
vomiting, a series of four cats was prepared acutely with spinal cord transection 
at T-5 combined with bilateral mid-cervical vagotomy so as to exclude all abdominal 
afferents. Two of the four animals vomited following nicotine bitartrate, thus 
indicating that any remaining spinal afferents involved in nicotine-induced emesis 
must traverse the upper thoracic dorsal roots. It was conclud~d from these acute 
experiments that the site of emetic action of nicotine was in the trunk and required 
vagal innervation as well as spinal afferents. 
3. Chronic Extramedullary Lesions. Since in acute experiments there is the 
possibility that the emetic refractoriness is due to a ~on-specific neuronal de-
pression from the surgical trauma, another series of cats was prepared with chronic 
extramedullary lesions of portions of the nervous system. An attempt was made 
thereby to determine the relative contribution of receptor sites in the abdominal 
and thoracic cavities. Three chronic cats were prepared with supradiaphragmatic 
vagotomy in combination with spinal cord transection at T-4. All three animals 
vomited following 3.0 mg./kg. I.M. nicotine bitartrate and each of two cats vomited 
in response to 2.0 mg./kg. I.M. lobeline sulfate. Chronic spinal cord transection 
at the level of the eighth cervical segment combined with supradiaphragmatic vagotomy 
in two animals also failed to make cats insensitive to the emetic action of 3.0 mg./k, 
nicotine and 3.0 mg./kg. lobeline. 
From the acute experiments described above, it would appear that emetic receptor 
sensitive to nicotine are located below the neck and that certain of the afferent 
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pathways concerned traverse the upper thoracic dorsal roots. On the other hand, 
results from the chronic experiments, when interpreted in the light of information 
gained from the acute experiments, demonstrated the importance of the thoracic 
component of the vagus nerves. In order to delimit further the spinal segments 
involved, the dorsal roots of a cat were sectioned bilaterally from T-l through 
T-IO and the vagi cut mid-cervically. This cat vomited in response to both nicotine 
and lobeline. It therefore appeared that afferent emetic fibers enter the spinal 
cord below the tenth thoracic segment as well as via the upper thoracic dorsal 
roots, while others traverse the vagus nerves. 
In order to establish more definitely whether this is the case, chronic animals 
were prepared in which a bilateral dorsal rhizot~ was performed from c-a to the 
mid-thoracic region and the spinal cord transected at the level of the lowest dorsal 
root section. In this way, the upper thoracic efferent roots were left intact, 
allowing the use of most of the intercostal musculature. The first of these cats 
vomited three minutes after intramuscular injection of 3.0 mg./kg. of nicotine 
bitartrate. The second cat was refractory to the emetic action of 3.0 but not 
6.0 mg./kg. nicotine bitartrate and 2.0 mg./kg. lobeline sulfate. The capability 
of the second cat to vomit having been demonstrated, the right vagus nerve was 
then sectioned intrathoracically just below the right subclavian artery and the 
left vagus nerve was sectioned mid-cervically. The cat was tested a few days later 
and it vomited following 6.0 mg./kg" nicotine bitartrate, with a prolonged 
latency (17 minutes). One more animal was prepared with right subclavian and 
left cervical vagotomy combined with bilateral dorsal rhizotomy of segments c-a 
through T-5 and spinal transection at T-5. The cat vomited to lobeline sulfate 
(3.0 mg./kg. 141M.) and to Veriloid (0.05 mg./kg. I.V.) but it did not vomit follow-
ing a second injection of the same dose of lobeline sulfate, or after nicotine 
bitartrate (6.0 mg./kg. 1 41M.). 
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In order to exclude the possibility that afferent impulses enter the vagus 
nerves between the subclavian and mid-cervical regions, bilateral dorsal rhizotomy 
of segments C-8 through T~8 and spinal transection at T-8 were combined with bilateraJ 
mid-cervical vagotomy in one chronic cat. Thus, the deafferentation of this animal 
was similar to that of the three acute preparations, previously described, which had 
resulted in unresponsiveness to 3.0 mg./kg. nicotine bitartrate. This chronic 
animal vomited following intramuscular injection of 6.0 mg./kg. of this drug with 
a latency of 5 minutes. 
4. Further Analysis of Medullary Lesions. The aforementioned series of ex-
tramedullary lesions effectively deafferented the medulla oblongata without pre-
venting vomiting to very large doses of nicotine and lobeline, but the emetic 
thresholds definitely were elevated. The only medullary lesion in the cat which 
had abolished the emetic response to all doses of these agents tested was the broad 
superficial ablation of the structures lateral from the floor of the fourth ventricle 
to the lateral margin of the clava, between the obex and the restiform bodies includ-
ing the CT-zone. In order to determine the degree of participation of the CT-zone 
in the vomiting response to nicotine, two cats were subjected to the extensive 
medullary lesion just described but with an attempt to spare the area postrema. 
Both cats vomited to apomorphine HCl'and to nicotine bitartrate (3.0 mg./kg. I.M.). 
One of these cats also vomited in response to desacetyl lanatoeide-C. This cat was 
subjected to right subclavian and left mid-cervical vagotomy. The animal again 
vomited in response to 3.0 mg./kg. I.M. nicotine bitartrate, thus demonstrating 
the importance of the CT-zone as a receptor site for nicotine-induced emesis. 
The necessity of interrupting the three afferent emetic pathways is confirmed 
by deafferenting the trunk in a cat with an effective chronic CT-zone ablation. 
An abbreviated protocol of the experiments performed on this cat (No. 36) is given 
below: 
10/11/56 CT-zone ablation. 
10/22/56 3.0 mg./kg. I.M. nicotine bitartrate. Vomited after 14 minutes. 
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10/24/56 2.0 mg./kg. I.M. lobeline sulfate. No vomiting. 
10/26/56 25 mg./kg. S.C. apomorphine HC1. No vomiting. 
10/29/56 3.0 mg./kg. I.M. nicotine bitartrate. No vomiting. 
10/31/56 2.0 mg./kg. I.M. lobeline sulfate. No vomiting. 
11/2/56 3.0 mg./kg. I.M. nicotine bitartrate. Vomited after 10 minutes. 
11/6/56 3.0 mg./kg. I.M. nicotine bitartrate. No vomiting. 
11/8/56 0.16 mg./kg. I.V. desacety1 lanatoside-C. No vomiting. 
11/13/56 6.0 mg./kg. I.M. niootine bitartrate. Retched after 18 minutes. 
11/21/56 6.0 mg./kg. I.M. nicotine bitartrate. Vomited after 11 minutes. 
11/28/56 6.0 mg./kg. I.M. nicotine bitartrate. Vomited after 19 minutes. 
12/7/56 3.0 mg./kg. I.M. nicotine bitartrate. Vomited after 8 ndnutes. 
1/22/57 25.0 mg./kg. S.C. apomorphine HCI. No vomiting, 
1/25/57 Left vocal cord removed. 
1/31/57 Bilateral mid-cervical vagotomy, bilateral dorsal rnizotomy (C-B to T-8) and spinal transection (T~8)~ 
2/3/57 
2/5/57 
6.0 mg./kg. I.M. nicotine bitartrate. No vomiting or signs of vomitinf 
6.0 mg./kg. I.M. nicotine bitartrate. No vomiting < or signs of vomiti~ 
C. Anti-Emetic Drug Studies. 
The results of tests with TEA and C6, as antagonists of the emetic action of 
nicotine and lobeline in both cats and dogs, are shown in figure 3. It will be 
seen that the uniformly effective emetic doses of 1.5 mg./kg. I.M. niootine bitar-
trate and 0.5 mg./kg. I.M. lobeline sulfate in cats were antagonized by prior 
administration of 20 mg./kg. I.M. of TEA. The same dose of TEA also was effective 
in dogs against nicotine bitartrate but not against lobeline sulfate. Indeed, TEA 
was not effective against lobeline-induced emesis in the dog in doses up to 40 mg./kgt 
In those animals in which emesis was blocked by TEA, the emetic prodromata were 
also blocked. Relaxation of the nictitating membrane was frequently, though not 
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failed to inhibit significantly the vomiting to 1.5 mg./kg. n1rcotine bitartrate 
in the dog, in spite of the fact that this dose of atropine caused depression 
and ataxia. The dose of 3.0 mg./kg. s.c. chlorprama~ine caused moderate nervous 
system depression and 6.0 mg./kg. caused marked depression of the animals tested. 
The latency of vomiting to nicotine and lobeline was not prolonged in cats but 




Possible sites of emetic action of nicotine and lobeline, taken into con-
sideration in the present study, are as follows: a) CT-zone; b) forebrain; 
c) cranial afferents; d) abdominal loci; e) thoracic loci. The strongest support 
for the CT-zone as the emetic receptor site for these alkaloids is obtained from 
the dog experiments in which all tests in CT-zone ablated animals demonstrated 
same degree of refractoriness to nicotine, at least to the extent of protection 
against the minimum uniformly effect.ive emetic dose established in normal dogs. 
In the cat, on the other hand, emetic responses to suprathreshold doses of 
nicotine and lobeline were only inconsistently blocked by ablation of the CT-zone. 
In view of the facts that protection from the emetic effects of radiation in the 
cat also was obtained inconsistently after CT-zone ablation and that protection 
regularly followed abdominal denervation (Borison, 1957), it appeared possible 
that the same pattern of innervation might apply to nicotine-induced emesis. 
The possible contribution of peripheral afferents to the vomiting evoked by 
nicotine was attacked in two ways. First, an attempt was made to interrupt spinal 
visceral afferents at the medullary level, by placing a bilateral incision in the 
dorsal surface of the medulla lateral to and parallel with the area postrema. 
The rationale for this procedure is provided by the histological data of Kuru 
(1955), Kuru and Sugihara (19,6), and Liu (1956), which demonstrate terminations 
from thoracic, lumbar, and sacral afferents in the vicinity of the dorsal vagal 
nuclei. This experimental approach did not elevate the emetic threshold to nicotine, 
either by itself or in combination with mid-cervical vagotomy. The second approach 
for interruption of spinal visceral afferents was the direct surgical section of 
afferent pathways at the segmental level. This is most readily accomplished in the 
acute decerebrate preparation under ether anesthesia. The emetic response to a 
suprathreshold dose of nicotine in the cat was not prevented by the combination of 
decerebration with section of cranial nerves V, IX, X, Xl, and XII, or by decere-
bration and high spinal cord section. 
'u 
In contrast, when afferents were interrupted acutely by spinal transection 
in combination with vagotomy but without decerebration, twice the minimum uniformly 
effective dose of nicotine failed to evoke emesis. This provided support for the 
suggestion that peripheral afferents contribute to the emetic response. However, 
negative results from acute experiments must be SUbstantiated in chronic prepara-
tions. Whereas data obtained in preparations with chronic visceral deafferentation 
did support the results obtained from the acute experiments, namely, by protecting 
against the same emetic dose level, vomiting could be evoked by still higher doses 
of nicotine. 
Since the separate procedures of trunk deafferentation and CT-zone ablation 
served independently to elevate the emetic threshold, it follows that the combination 
of these procedures might eliminate the residual sensitivity to nicotine. The 
combination of these operations blocked the vomiting to the highest dose level of 
nicotine tested in this study, that is, 6 mg.!kg. administered intramuscularly. 
Hence, it is evident that stimulation of more than a single receptor site is 
responsible for the emetic response to nicotine. Further support for a dual 
mechanism of emetic stimulation was obtained by the surgical procedure of extend-
ing the CT-lesion laterally so as to include, in addition, the visceral afferents 
coursing over the dorsal surface of the medulla. This procedure also resulted in 
refractoriness to the highest dose of nicotine employed. 
The participation of vagal afferents in the emetic response was demonstrated 
by the fact that mid-cervical vagotomy in combination with high cord section 
regularly caused an elevation in threshold, whereas cord section alone did not. 
The effect of mid-cervical vagotomy also was manifest at times by an increase in 
the latency of vomiting. In contrast, supradiaphragmatic vagotomy was ineffective 
in producing detectable changes in threshold or latency. This result, coupled 
with the fact that spinal deafferentation inclusive of the upper thoracic segments 
was required in order to elevate the emetic threshold, indicates that trunk 
receptors for nicotine are located in the thorax as well as in the abdomen. 
The importance of the vagus as an afferent source of emetic impulses has 
long been appreciated. Indeed, the emetic action of veratrum at the nodose 
ganglion of the vagus (Borison and Fairbanks, 1952) probably represents in 
large measure drug facilitation of subliminal afferent vagal activity. Accord-
ingly, consideration must be given to the effect of lesions in the dorsal vagal 
nuclei of the medulla. It is evident that the threshold elevating'effect of CT-
zone ablation on nicotine-induced emesis cannot be attributed to damage of the 
dorsal vagal nuclei since vagotomy alone produced no such effect. On the other 
hand, failure to block nicotine-induced vomiting by the medullary lateral lesions, 
which were designed to interrupt spinal visceral afferents centrally but which 
avoided the CT-zone, may have been the result of central vagal sparing since cord 
section alone was ineffective in blocking the vomiting. Thus one could predict 
that the most effective central lesion would include the vagal nuclei medially, 
the CT-zone in the area postrema., and the spinal visceral afferent pathways 
laterally, all of which contribute to the emetic response. 
Many species differences exist in responses to emetic stimuli. For example, 
the effective emetic dose of apomorphine in the cat is approximately lODO-fold 
greater than in the dog, and ergot,which readily produces vomiting in dog~,fails 
completely to evoke emesis in the cat. Chlorpromazine, on the other hand, which 
serves to protect dogs against certain centrallY-acting emetic agents, has 
exhibited no protective effect in cats. From the morphological standpoint, it 
has been difficult in the dog to separate surgically the receptor elements for 
apomorphine and the cardiac glycosidesj in contrast, this separation of receptors 
has been easily attained in the eat. The RESULTS show that refractoriness to 
IotV. cardiac glycosides results more consistently from CT-zone ablation than does 
refractoriness to apomorphine. This finding confir.ms results previously reported 
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from this laboratory (Borison, 1957). Differentiation of receptors for nicotine 
from those for apomorphine and the cardiac glycosides is provided by anti-emetic 
protection as well as by surgical fractionation of the CT-zone. TEA blocks the 
vomiting response to nicotine, in dogs as well as cats, but does not alter the 
response to the cardiae glycosides and apomorphine (Busse and Lendle, 1953). 
Chlorpromazine, in contrast, protects dogs against apomorphine but not against 
nicotine (see RESULTS) and the cardiac glycosides (Brand .!!: ~., 1954; Glaviano 
and Wang, 1955). 
The apparent discrepancy in the effectiveness of CT-zone ablation against 
nicotine-induced vomiting in dogs versus cats finds its counterpart in X-radiation-
induced emesis. The most plausible explanation for the species difference is that 
central pathways for afferent emetic tmpulses are more tightly tunneled through 
the region of the CT-zone in the dog than in the cat. Thus a discrete lesion in 
the CT-zone of the dog would be expected to interrupt more emet~c afferents of 
different origin than it would in the cat. This could explain also why the 
receptor elements for the cardiac glycosides and apomorphine are not easily 
separated by surgical means in the dog. 
At first sight it would appear that nicotine might be acting at ganglionic 
sites to produce emesis. The fact that TEA and c6 block nicotine-induced vomiting 
seems ~o support this postulate. However, nicotine and lobeline are known to stimu-
late many extra-ganglionic loci, for example, sensory receptors in the skin and 
mesentery (Brown and Gray, 1948), carotid and aortic chemoreceptors (Moe ~ !l., 
1945), and pleural pain receptors (Eckenhoff and Comroe, 1951). Eckenhoff and Comroe 
have shown further that premedication with TEA prevents lobeline-induced substernal 
pain. In addition, the direct vasoconstrictive action of nicotine on the vascular 
smooth muscle of the perfused rabbit ear can be eliminated by injection of TEA or 
c6. Thus, it can be seen that the classical concept of a functional action of 
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nicotine and lobeline, and of the "ganglionic-blocking agents" TEA and C6, does 
not explain adequately the recent findings wtth these substa.nces. Similarly, it 
is evident that the loci for emetiQ action of nicotine and lob~line elucidated 
in the present study also are extra-ganglionic. 
45 
SUMMARY 
The emetic action of nicotine and lobeline was studied in cats and dogs. 
The minimal uniformly effective emetic doses were found to be 1.5 mg./kg. I.M. 
nicotine bitartrate and 0.5 mg./kg. I.M. lobeline sulfate. In ~erms of the alkaloid 
base, the dose-response relationship coincided, for practical purposes, at all dose 
levels studied. 
Sixty-six cats and ten dogs were used to establish the locus of the emetic 
action of the alkaloids. It was found, in cats, that the agents stimulated two 
different sites of action, namely, a peripheral locus (or 10c1)as well as the 
CT-zone. Therefore, in order to eliminate the vomiting response to nicotine and 
lobeline in cats, it was necessary to combine the following pro'cedu:res: spinal 
visceral deafferentation, vagotomy, and CT-zone ablation, The combination of these 
lesions was accomplished either by peripheral nerve sections in combination with 
CT-zone ablation or by a broad medullary lesion which destroyed both the CT-zone 
and incoming visceral afferents. In dogs, CT-zone ablation alone sufficed to 
protect animals against the emetic effect of nicotine and lobeline. The implication 
of these results is discussed in light of investigations on species variations pre-
viously reported in this field. 
Anti-emetic drug studies were also included in the present investigation. 
Tetraethylammonium (TEA) was effective in preventing emesis in response to nicotine 
in both cats and dogs, but it was effective only against lobeline in cats. Hexa-
methonium (C6) protected both species against uniformly effective emetic doses of 
nicotine and lobeline. Neither atropine nor chlorpromazine was found significantly 
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